#potstocks

Dm us.#potstocks #PUBLICIST #wallstreet #pennystocks #traders #brokers #business #forex #fx #otc #bigpharma #bitcoin #leverage

$TLRY and #ACB….#PotStocks $CGC $ACB $SNDL #crypto #bitcoin #eth #doge https://www.instagram.com/p/CP3wJB_HsMm/?utm_medium=tumblr

$SNDL $HEXO $MCOA $CBDD Global $147.45 Billion Cannabis Market Forecast to 2027: Growing Acceptance of Cannabis Products Gaining Momentum https://www.globenewswire.com/news-release/2020/12/08/2141080/0/en/Global-147-45-Billion-Cannabis-Market-Forecast-to-2027-Growing-Acceptance-of-Cannabis-Products-Gaining-Momentum.html #pennystocks #potstocks #weedcomunity #invest https://www.instagram.com/p/CIi0hl1jtTr/?igshid=1ixbosq2xjqpd

The CBD space is more and more receiving attention as perhaps the real bloom on the flower of the cannabis movement in terms of economic and financial opportunities. It’s just a fact: most people aren’t ever going to be interested in smoking pot. But everyone wants to feel better, more healthy, more relaxed, and to have more tools for subjective well-being, without “getting high” necessarily being part of the equation. The cannabis plant has been the focus of research – both anecdotal and formal – that has started to establish a number of positive benefits. CBD is the path that harnesses those positive factors without forcing one to engage in the psychoactive elements that come with the THC package. That very directly represents a larger total addressable market. As the stigma attached to the cannabis plant inevitably drops away, we are left with this big market opportunity – essentially, the process of a transition from a small niche market worth maybe $50 million in sales 6-8 years ago to a monster global juggernaut worth as much as $25-50 billion according to some estimates over coming years. With that in mind, we take a look at a few of the most interesting and compelling names in the CBD space, including: Cronos Group Inc (NASDAQ:CRON), cbdMD Inc (NYSEAMERICAN:YCBD), CBD of Denver Inc. (OTCMKTS:CBDD), and Neptune Wellness Solutions Inc (NASDAQ:NEPT). Cronos Group Inc (NASDAQ:CRON) has a strong emphasis on medical marijuana and cannabis-related research and products. In short, the company seeks to invest in other companies, either licensed or actively seeking a license, to produce medical marijuana pursuant to Canada’s Marijuana for Medical Purposes Regulations (MMPR). The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment but does not need control. Cronos Group Inc (NASDAQ:CRON) just announced its 2020 second quarter business results. “In the second quarter of 2020, we continued our progress despite unprecedented shifts in our industry and the global economy. We officially entered the Israeli medical cannabis market, with Cronos Israel commencing the sale of PEACE NATURALS™ branded dried flower products to medical patients. During these extraordinary times, it is very encouraging to see that we are making progress against our strategy across our global footprint," said Mike Gorenstein, CEO of Cronos Group. "While following safety guidelines, our employees are finding new and creative ways to keep our production, manufacturing, and R&D facilities operating, and we are bringing new products and brands to markets across the globe. Cronos Group was founded on the mission to improve people’s lives by unlocking the full potential of cannabis and our Company is very proud to be at the forefront of providing safe access and high-quality products to patients and consumers around the world.” The stock has suffered a bit of late, with shares of CRON taking a hit in recent action, down about -17% over the past week. Cronos Group Inc (NASDAQ:CRON) generated sales of $13.7M, according to information released in the company's most recent quarterly financial report. That adds up to a sequential quarter-over-quarter growth rate of 20.7% on the top line. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($1.8B against $320.4M). cbdMD Inc (NYSEAMERICAN:YCBD) produces and distributes various cannibidiol (CBD) products. It owns and operates the consumer hemp-based CBD brand, cbdMD. The company's product categories include CBD tinctures, capsules, gummies, bath bombs, topical creams, and animal treats and oils. It also offers pet related CBD products under the Paw CBD brand name.  The company distributes its products through an e-commerce Website, wholesalers, and various brick and mortar retailers in the United States. cbdMD Inc (NYSEAMERICAN:YCBD) just announced that it has filed a new patent application with the U.S. Patent and Trademark Office which will allow it to pursue patented protection in several key areas, including novel formulations and delivery systems, as well as methods of manufacturing and use.  According to the release, the recent submission by the company is part of its ongoing intellectual property strategy to ensure appropriate protection around its product lines and to be forward-thinking as to the direction of the CBD market. Even in light of this news, YCBD has had a rough past week of trading action, with shares sinking something like -7% in that time. That said, chart support is nearby and we may be in the process of constructing a nice setup for some movement back the other way. cbdMD Inc (NYSEAMERICAN:YCBD) generated sales of $9.4M, according to information released in the company's most recent quarterly financial report. That adds up to a sequential quarter-over-quarter growth rate of -7.4% on the top line. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($14.9M against $5.8M). CBD of Denver Inc. (OTCMKTS:CBDD) engages in developing and commercializing cannabidiol (CBD) products. It is involved in the research, development, and distribution of premium hemp extract products. CBD of Denver Inc. operates as a subsidiary of Swiss Industry Ventures AG. CBDD is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for shareholders. The company just put out a powerful corporate update that noted that CBDD's Rockflowr, GmbH subsidiary, just purchased a new vacuum packaging machine for flowers and is in the process of shipping sample packs to CBD stores throughout Europe.  Rockflowr is also pleased to announce it opened its first account in France. The first sale was for more than 52,000 CHF (approximately $57,00) and we received an additional order for 72,500 (approximately $79,000).  We have also been contacted by several other buyers and hope to be able to sell more product to France in the near future.  CBD Welt 24, GmbH, is on schedule to have harvests every month.  CBD Welt just sold its harvest from July to the same group that purchased the prior month's harvest. We are currently working on a new website for CBD Welt 24 and will have online live cameras for each facility.  When we finish with our updates, we will link the website to the CBD Corporate website. CBD of Denver Inc. (OTCMKTS:CBDD) is developing 3 new products for their Black Pearl CBD website.  The first product is a CBN/CBG gel cap which will be sold in 30 count per bottle.  Reports show that CBN and CBG can help with sleep and relaxation.  The second product is a CBD pain stick containing 3.8% full spectrum CBD and the third product, which will be introduced last, is a CBD lotion, to help skin look younger and relieve pain. CBDD offers a superior CBD product that is full spectrum without depending on THC to activate the benefits of the cannabidiol. According to company materials, CBDD was created to offer the consumer a unique and new perspective on the unorganized and confusing CBD industry. CBD of Denver, Inc. is the only company to release a comprehensive CBD Social Network (www.cbdsocialnetwork.com). The idea of the network is to connect CBD users from America and around the world to interact and discuss CBD uses, treatments and products. The site has been active for 3 months and already receives 2000-2500 hits a day. CBD of Denver Inc. (OTCMKTS:CBDD) just posted a net profit in Q2, which is the first time in the company’s history that it has achieved that milestone, which the company rightly sees as an indication of being on the right course in terms of providing value for its shareholders. Neptune Wellness Solutions Inc (NASDAQ:NEPT) operates as a health and wellness products company. The company operates through two segments, Nutraceutical and Cannabis. The Nutraceutical segment offers turnkey solutions, such as raw material sourcing, formulation, quality control, and quality assurance for omega-3 and hemp-derived ingredients under different delivery forms, including softgels, capsules, and liquids.  The Cannabis segment provides extraction and purification services from cannabis and hemp biomass. The company also offers formulation and manufacturing solutions for value added product forms, such as tinctures, sprays, topicals, vapor products, edibles, and beverages. It offers its products under the Forest Remedies and Ocean Remedies brand.  Neptune Wellness Solutions Inc (NASDAQ:NEPT) just announced the appointment of Eric Gharakhanian , Ph.D. as Director of Product Development, Health & Wellness Innovations. According to the release, Dr. Gharakhanian will be responsible for developing and building Neptune's portfolio of health and wellness products across personal care and homecare, with a focus on sustainable and natural plant-based sanitization wipes, hand sanitizers and other innovations. And the stock has been acting well over recent days, up something like 4% in that time. NEPT shares have been relatively flat over the past month of action, with very little net movement during that period.  Neptune Wellness Solutions Inc (NASDAQ:NEPT) managed to rope in revenues totaling $9.5M in overall sales during the company's most recently reported quarterly financial data -- a figure that represents a rate of top line growth of 68.3%, as compared to year-ago data in comparable terms. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($16.6M against $17.2M, respectively). Read the full article

With all the hoopla over the cannabis market, its younger brother is a more promising star: CBD. The CBD market wins over the cannabis market because it doesn’t have any hurdles to jump – that means legal or cultural – on its way to billions in total global sales. It just needs greater visibility. Cannabis is expected to grow by leaps and bounds, but it suffers from both legal and cultural pushback. It isn’t just about legality here. Decades of disinformation and legacy norm boundaries have dealt cannabis a heavy toll in the PR department, and that ground isn’t easy to make up in a hurry. But none of that exists in any important way for CBD because all of that is really about THC. Furthermore, there are other “innocent” cannabinoids to talk about next, including CBG, CBN, THCV, CBDA, etc. Each can get in line for its own coming out party over coming years. But the winner right now, according to experts and analysts, is CBD. One recent piece of research (May 2020, Industryresearch.biz) for strictly CBD oil shows growth expectations at a CAGR of roughly 32.0% over the next five years, to reach over $1.25 billion by 2024, up from $311.8 million in 2019. These numbers are smaller simply because this is the market for CBD by itself. The market for CBD-based products is much larger, and will grow to be many times this size over the same period, with analysts calling for $15-25 billion in sales by 2025. Grand View Research, for example, puts the global cannabidiol-based products market at a value of $4.6 billion already by 2018. Their research suggests it will grow by over 22% CAGR from 2019 to 2025 to reach nearly $19 billion. With that in mind, we take a look at a selection of active CBD stocks, including cbdMD Inc (NYSEAMERICAN:YCBD), Medical Marijuana Inc (OTCMKTS:MJNA), Cannabis Global Inc (OTCMKTS:CBGL), CBD of Denver Inc (OTCMKTS:CBDD), and Charlotte's Web Holdings Inc (OTCMKTS:CWBHF). cbdMD Inc (NYSEAMERICAN:YCBD) owns and operates the consumer hemp-based CBD brand, cbdMD. The company's product categories include CBD tinctures, capsules, gummies, bath bombs, topical creams, and animal treats and oils.  It also offers pet related CBD products under the Paw CBD brand name. The company distributes its products through an e-commerce Website, wholesalers, and various brick and mortar retailers in the United States. cbdMD Inc (NYSEAMERICAN:YCBD) just announced that its pet CBD brand, Paw CBD, has seen an approximate 64% increase in net sales from its March 2020 quarter of approximately $750,000 to approximately $1,229,000 for its June 2020 quarter. "Paw CBD was launched less than one year ago, and now it is one of America’s leading CBD pet brands," said Ken Cohn, CMO of cbdMD, Inc. "Sales metrics are all moving in the right direction, with Paw CBD now trending at over a $7mm annualized run rate, and cbdMD’s overall direct-to-consumer (DTC) sales making up over 70% of the brand’s revenue. We are seeing the DTC power of cbdMD.com translating into significant growth for PawCBD.com." The context for this announcement is a bit of a bid, with shares acting well over the past five days, up about 11% in that timeframe. Shares of the stock have powered higher over the past month, rallying roughly 54% in that time on strong overall action. cbdMD Inc (NYSEAMERICAN:YCBD) pulled in sales of $9.4M in its last reported quarterly financials, representing top line growth of 65.7%. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($14.9M against $5.8M). Medical Marijuana Inc (OTCMKTS:MJNA) bills itself as an investment holding company that operates in the medical marijuana and industrial hemp markets, including CBD products. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries. The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry.  It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products. In addition, the company provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics, and consulting and securities services to businesses and individuals in the legal cannabis industry.  Medical Marijuana Inc (OTCMKTS:MJNA) just recently announced that its subsidiary Kannaway is proud to support the European Industrial Hemp Association (EIHA) in its recent opinion letter to the European Commission on the legal status of cannabidiol (CBD) and hemp.  EIHA’s letter was written in response to the European Commission’s decision to suspend all applications for hemp extracts and natural cannabinoids under the European Union’s Novel Food rules and also deem under a “preliminary conclusion” that extracts from the flowering and fruiting tops of the hemp plant should be considered a drug under the United Nations Single Convention on Narcotic Drugs of 1961. EIHA explains that the decision is “not based on the latest scientific literature nor inspired by the current debate at the United Nations level.” Even in light of this news, MJNA has had a rough past week of trading action, with shares sinking something like -5% in that time. That said, chart support is nearby, and we may be in the process of constructing a nice setup for some movement back the other way. Over the past month, shares of the stock have suffered from clear selling pressure, dropping by roughly -13%.  Medical Marijuana Inc (OTCMKTS:MJNA) managed to rope in revenues totaling $13.4M in overall sales during the company's most recently reported quarterly financial data -- a figure that represents a rate of top line growth of -34%, as compared to year-ago data in comparable terms. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($5M against $11.1M, respectively). Cannabis Global Inc (OTCMKTS:CBGL) is one of the most interesting and possibly undervalued names in the space given its strong IP backing – with more than a half dozen provisional patents in process at the USPTO – and its innovative movement toward non-CBD cannabinoid production technology, suggesting the company will be at the vanguard of any move to establish the more exotic cannabinoids as commercial-scale markets. One of the key moves made recently by the company is its venture into the alcohol substitute mixing space. According to its recent release, Hemp You Can Feel™ mixers are now available for online consumer purchase as well as bulk purchase for wholesale distribution. Cocktails based on the Hemp You Can Feel™ mixers provide an experience on par with light alcohol consumption, but without any of the harmful side effects of alcohol. "Because of the ultra-low levels of hemp extracts utilized, we feel we set a new standard for product-safety and satisfaction in the hemp food and beverage category with this product," commented Arman Tabatabaei, CEO of Cannabis Global. "While our Hemp You Can Feel™ beverages likely have the lowest hemp extract levels in the industry, we believe we provide a vastly superior positive effect upon use. We invite all consumers and alcohol industry participants to try what we see as the first viable alternative to alcoholic beverages. Our website is www.HempYouCanFeel.com. Take the HempYouCanFeel Challenge!" Cannabis Global Inc (OTCMKTS:CBGL) believes the use of Hemp You Can Feel™ is significantly safer than the consumption of other hemp-based or high-cannabidiol (CBD) based beverages. Because of the natural water solubility of the preparations, only a minuscule amount of hemp extracts is present in the cocktail mixers. Laboratory analysis and results by High Performance Liquid Chromatography (HPLC) indicated the presence of hemp extracts in the non-detectable category. Shares of CBGL are testing key support in recent action, and have a history of sharp runs off of support when challenged. We would also note that the company has been get more and more catalysts out in the public eye in recent weeks suggesting that something new and positive is usually on the way to fuel the next move. Cannabis Global Inc (OTCMKTS:CBGL) had no reported sales in its last quarterly financial data. But it appears to be closing in on commercial-stage operational gains for shareholders and has a strong IP edge in the industry.  CBD of Denver Inc. (OTCMKTS:CBDD) is another less well-known name making strong strides in the space. The company engages in developing and commercializing cannabidiol (CBD) products. It is involved in the research, development, and distribution of premium hemp extract products. CBD of Denver Inc. operates as a subsidiary of Swiss Industry Ventures AG. CBDD is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for shareholders. CBDD offers a superior CBD product that is full spectrum without depending on THC to activate the benefits of the cannabidiol. According to company materials, CBDD was created to offer the consumer a unique and new perspective on the unorganized and confusing CBD industry. CBD of Denver, Inc. is the only company to release a comprehensive CBD Social Network (www.cbdsocialnetwork.com). The idea of the network is to connect CBD users from America and around the world to interact and discuss CBD uses, treatments and products. The site has been active for 3 months and already receives 2000-2500 hits a day. CBD of Denver Inc. (OTCMKTS:CBDD) just put out a recent announcement providing additional information on the revenue reported for Rockflowr, GmbH and CBD Welt 24, GmbH. According to the release, revenue for Rockflowr and CBD Welt 24, subsidiaries of CBD of Denver, Inc., was reported in CBDD's 2nd Quarter Disclosure with OTC Markets as of the date each company was acquired and not for their own full quarter. To provide context for the revenue numbers reported in CBDD's quarterly statement, CBBD is providing the revenue generated by Rockflowr and CBD Welt24 for their full quarters and not just since they were acquired by CBDD in the middle of quarter.  Rockflower: For the period from April 1, 2020 through June 30, 2020 Rockflowr had revenue of 1,710,000.00 CHF or approximately $1,833,120.00 USD with net profits of 131,089 CHF or approximately $140,527 USD. CBD Welt 24: For the period from April 1, 2020 through June 30, 2020 CBD Welt24 had revenue of 56,500.00 CHF or approximately $60,568,00 with a net profit 45,416 CHF of approximately $48,686 USD.  This amount only reflects revenue after the first harvest as it took two months from initial planting until first harvest to generate revenue.  Moving forward, CBD Welt24 expects a harvest every month that should substantially increase revenue. CBD of Denver Inc. (OTCMKTS:CBDD) just posted a net profit in Q2, which is the first time in the company’s history that it has achieved that milestone, which the company rightly sees as an indication of being on the right course in terms of providing value for its shareholders. Charlotte's Web Holdings Inc (OTCMKTS:CWBHF) develops and distributes hemp-based cannabidiol (CBD) wellness products. Its products include CBD hemp oils, capsules, topicals, and pet products that feature CBD hemp oil extracts. Charlotte's Web Holdings, Inc. sells its products online as well as through distributors, and brick and mortar retailers.  Charlotte's Web Holdings, Inc. is a market leader in the production and distribution of innovative hemp-based cannabidiol wellness products. Founded by the Stanley Brothers, the Company's premium quality products start with proprietary hemp genetics that are responsibly manufactured into whole plant hemp extracts naturally containing a full spectrum of phytocannabinoids, including CBD, terpenes, flavonoids and other beneficial hemp compounds. Industrial hemp products are non-intoxicating.  Charlotte's Web Holdings Inc (OTCMKTS:CWBHF) recently announced its "Trust The Earth" initiative, which is designed to democratize access to hemp-derived products for those seeking wellness and relief.   Studio Number One, a creative agency co-founded by artist Shepard Fairey, created the original artwork, first publicly exhibited by Charlotte's Web as a mural in Brooklyn in October 2019.  Today, Studio Number One's original art is exhibited from the ground up, literally, as field art on a mammoth scale of 76-acres in America's heartland. Even in light of this news, CWBHF has had a rough past week of trading action, with shares sinking something like -5% in that time. That said, chart support is nearby, and we may be in the process of constructing a nice setup for some movement back the other way. Charlotte's Web Holdings Inc (OTCMKTS:CWBHF) pulled in sales of $28.9M in its last reported quarterly financials, representing top line growth of 0.1%. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($75.5M against $42.2M). Read the full article

Cannabinoids are still a new marketplace. Even though weed has been around for a long time, and everyone knows it on some level, the notion of a class of compounds with a variety of different potential uses for people on an everyday scale is still something investors are getting used to. But the growth data in the space is undeniable. And it may just be the tip of the iceberg. CBD is the huge star right now in terms of future growth potential, with THC actually trailing by a length according to analysts – because not everyone wants to get “high”. However, there are a host of other potential stars on the way, including Tetrahydrocannabinolic Acid (THCA), Cannabidiolic Acid (CBDA), Cannabinol (CBN), Cannabigerol (CBG), Cannabichromene (CBC), Tetrahydrocannabivarin (THCV), Cannabidivarin (CBDV), and others. Companies already with an edge in the CBD space may be the best candidates for transitioning into other cannabinoids if and when they catch fire. With that in mind, we take a look at a few of the most interesting and compelling names in the CBD space, including: Cronos Group Inc (NASDAQ:CRON), cbdMD Inc (NYSEAMERICAN:YCBD), Cannabis Global, Inc. (OTCMKTS:CBGL), and Neptune Wellness Solutions Inc (NASDAQ:NEPT). Cronos Group Inc (NASDAQ:CRON) casts itself as an investment firm in the biopharmaceutical space, with a strong emphasis on medical marijuana and cannabis-related research and products. In short, the company seeks to invest in other companies, either licensed or actively seeking a license, to produce medical marijuana pursuant to Canada’s Marijuana for Medical Purposes Regulations (MMPR). The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment but does not need control. Cronos Group Inc (NASDAQ:CRON) distributes its products across five different continents. The company drives several brands in the space, including PEACE NATURALS, COVE, Spinach, 2 adult-use brands, Lord Jones, and PEACE+, and 2 hemp-derived CBD brands.  If you're long this stock, then you're liking how the stock has responded to the announcement. CRON shares have been moving higher over the past week overall, pushing about 0% to the upside on above average trading volume. Shares of the stock have powered higher over the past month, rallying roughly 13% in that time on strong overall action.  Cronos Group Inc (NASDAQ:CRON) pulled in sales of $11.3M in its last reported quarterly financials, representing top line growth of 184%. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($1.9B against $286.8M). cbdMD Inc (NYSEAMERICAN:YCBD) just announced that it has filed a new patent application with the U.S. Patent and Trademark Office which will allow it to pursue patented protection in several key areas, including novel formulations and delivery systems, as well as methods of manufacturing and use.  According to the release, the recent submission by the company is part of its ongoing intellectual property strategy to ensure appropriate protection around its product lines and to be forward-thinking as to the direction of the CBD market. cbdMD Inc (NYSEAMERICAN:YCBD) produces and distributes various cannibidiol (CBD) products. It owns and operates the consumer hemp-based CBD brand, cbdMD. The company's product categories include CBD tinctures, capsules, gummies, bath bombs, topical creams, and animal treats and oils. It also offers pet related CBD products under the Paw CBD brand name. The company distributes its products through an e-commerce Website, wholesalers, and various brick and mortar retailers in the United States. The context for its recent announcement is a bit of a bid, with shares acting well over the past five days, up about 11% in that timeframe. Shares of the stock have powered higher over the past month, rallying roughly 46% in that time on strong overall action.  cbdMD Inc (NYSEAMERICAN:YCBD) generated sales of $9.4M, according to information released in the company's most recent quarterly financial report. That adds up to a sequential quarter-over-quarter growth rate of -7.4% on the top line. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($14.9M against $5.8M). Cannabis Global Inc (OTCMKTS:CBGL) is a more speculative name, but one with strong IP in place, including a number of provisional patents in process at the USPTO. The company was formerly known as MCTC Holdings, Inc. (OTC PINK:MCTC), dba Cannabis Global Inc., a cannabinoid and hemp extract science forward company developing infusion and delivery technologies. Earlier this week, it got word from FINRA that the name and ticker changes were approved, bringing the company’s overall market identity into a much more coherent and cohesive form, which is more important than you might think. "We have come a long way in only one year," commented Arman Tabatabaei, chief executive officer. "During this year we have reorganized the Company, instituted a robust cannabinoid-oriented R&D program, filed six provisional patents on the developed technologies, all while developing a host of consumer and industry products utilizing the inventions. We are very pleased to announce our corporate name change to Cannabis Global, Inc., and the new CBGL trading symbol." Cannabis Global Inc (OTCMKTS:CBGL) also noted in the release that it plans to continue its focus on hemp extract products based on unique infusion technologies. Over the coming months, the Company expects to launch a series of innovative products in the areas of beverages, foods, and food company functional ingredients. The Company's focus on honey-bee hemp infusions and rare cannabinoids, such as Tetrahydrocannabivarin (THC-V) and Cannabinol (CBN), will continue, as will its focus on scientific studies relating to the infusion technologies. The company’s most recent breakthrough move is its THCV mouse study now underway, which could produce critical data that advances our understanding of this unique cannabinoid and its potential as a diet and weight loss supplement. If that study produces compelling results, the company could gain in value since it may be the only commercially scalable source of THCV. Cannabis Global Inc (OTCMKTS:CBGL) had no reported sales in its last quarterly financial data. But it appears to be closing in on commercial-stage operational gains for shareholders and has a strong IP edge in the industry. Neptune Wellness Solutions Inc (NASDAQ:NEPT) frames itself as a company that operates as a health and wellness products company. The company operates through two segments, Nutraceutical and Cannabis. The Nutraceutical segment offers turnkey solutions, such as raw material sourcing, formulation, quality control, and quality assurance for omega-3 and hemp-derived ingredients under different delivery forms, including softgels, capsules, and liquids.  The Cannabis segment provides extraction and purification services from cannabis and hemp biomass. The company also offers formulation and manufacturing solutions for value added product forms, such as tinctures, sprays, topicals, vapor products, edibles, and beverages. It offers its products under the Forest Remedies and Ocean Remedies brand.  Neptune Wellness Solutions Inc (NASDAQ:NEPT) just announced the appointment of Eric Gharakhanian , Ph.D. as Director of Product Development, Health & Wellness Innovations. According to the release, Dr. Gharakhanian will be responsible for developing and building Neptune's portfolio of health and wellness products across personal care and homecare, with a focus on sustainable and natural plant-based sanitization wipes, hand sanitizers and other innovations. And the stock has been acting well over recent days, up something like 4% in that time. NEPT shares have been relatively flat over the past month of action, with very little net movement during that period.  Neptune Wellness Solutions Inc (NASDAQ:NEPT) managed to rope in revenues totaling $9.5M in overall sales during the company's most recently reported quarterly financial data -- a figure that represents a rate of top line growth of 68.3%, as compared to year-ago data in comparable terms. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($16.6M against $17.2M, respectively). Read the full article

It’s not a mystery where to find strong growth. As the bull market rages on, driven by extreme monetary and fiscal policy support amid historic challenges, the only way for investors to truly lose the game is to not play. Just about anything else has been working. But the chapter ahead will likely take a bit more nuance. The division between the pandemic plays and the rest of the market is obvious. And money managers diversifying between the two are doing well. But it’s not easy to find opportunities that have a viable long-term growth thesis but are still trading at a strong value relative to the market. One area that could become of increasing interest is in the cannabis space, where the long-term growth outlook is tremendous, but flows have yet to surge into the space. Most cannabis plays are still trading at 1-2x sales despite forward topline growth forecasts above 20% over the coming four quarters.  That’s a disposition that is increasingly rare. With that in mind, we take a look at five cannabis plays that are actively traded and continue to post strong performance data while making significant investments at a strong ROI, including: Curaleaf Holdings Inc (OTCMKTS:CURLF), Green Thumb Industries Inc (OTCMKTS:GTBIF), Trulieve Cannabis Corp (OTCMKTS:TCNNF), Sugarmade Inc (OTCMKTS:SGMD), and Cresco Labs Inc (OTCMKTS:CRLBF) Curaleaf Holdings Inc (OTCMKTS:CURLF) recently announced the launch of Curaleaf Sublingual Tablets in Florida. These cube-shaped, berry-flavored bites will provide the state's medical patients with a discreet, sugar-free yet fruity alternative form of medication. According to the release, Curaleaf's new Sublingual Tablets, which will be in 30-piece jars, contain 5mg of high-quality cannabis oil per piece, which allows patients to manage their treatment plan with confidence and ease. Each bite, which is made to be ingested orally or sublingually, is translucent in color and features a refreshing "Arctic Berry" flavor. The new product will be sold at all of the Company's 28 operating dispensaries in Florida with a phased roll-out between August 8th - August 20th. Limited quantities will be released to pre-existing loyalty patients beginning tomorrow, July 30th. Curaleaf Holdings Inc (OTCMKTS:CURLF) promulgates itself as a company that operates as an integrated medical and wellness cannabis operator in the United States. The Company is the parent of Curaleaf, Inc., a leading vertically integrated cannabis operator in the United States. Headquartered in Wakefield, Massachusetts, Curaleaf, Inc. has a presence in 12 states.  Curaleaf Inc.'s Florida operations were the first in the cannabis industry to receive the Safe Quality Food certification under the Global Food Safety Initiative, setting a new standard of excellence. It cultivates, processes, markets, and/or dispenses a range of cannabis products in various operating markets, including flower, pre-rolls and flower pods, dry-herb vaporizer cartridges, concentrates for vaporizing, concentrates for dabbing, tinctures, lozenges, capsules, and edibles.  Curaleaf Holdings Inc (OTCMKTS:CURLF) also provides non-cannabis services to licensed cannabis operators in the areas of cultivation, extraction and production, and retail operations. As of November 01, 2018, it operated a network of 29 dispensaries. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts. Green Thumb Industries Inc (OTCMKTS:GTBIF) recently announced that it opened Essence South Durango, on June 27. This has been one of the fastest growing MSO’s in the wider cannabis space. According to the release, this is Green Thumb’s fifth Essence store in the Las Vegas area and 48th retail location in the nation. Profits from the first day of sales will be donated to Last Prisoner Project, a nonprofit coalition of cannabis industry leaders, executives, and artists dedicated to bringing restorative justice to the cannabis industry. Green Thumb Industries Inc (OTCMKTS:GTBIF) bills itself as a company that manufactures and sells various cannabis products in the United States. The company’s cannabis products include flower, concentrates for dabbing and vaporizing, edibles, and topicals. According to company materials, “Green Thumb Industries (GTI), a national cannabis cultivator, processor and dispensary operator, is dedicated to providing dignified access to safe and effective cannabis nationwide while giving back to the communities in which they serve. As a vertically integrated company, GTI manufactures and sells a well-rounded suite of branded cannabis products including flower, concentrates, edibles, and topicals. The company also owns and operates a rapidly growing national chain of retail cannabis stores called RISE(TM) dispensaries. Headquartered in Chicago, Illinois, GTI has seven manufacturing facilities and licenses for 50 retail locations across seven highly regulated U.S. markets. Established in 2014, GTI employs more than 350 people and serves hundreds of thousands of patients and customers each year. GTI was named a Best Workplace 2018 by Crain’s Chicago Business.” Green Thumb Industries Inc (OTCMKTS:GTBIF) markets its products through third-party retailers. It also owns and operates a chain of 50 retail stores under the RISE dispensaries name. The company was founded in 2014 and is headquartered in Chicago, Illinois. Trulieve Cannabis Corp (OTCMKTS:TCNNF) just announced the opening of its latest storefront: Tarpon Springs will be home to the Company's 53rd dispensary in the state of Florida and 55th nationwide. According to the release, situated next to Lake Tarpon, the dispensary supports Trulieve's goal of expanding and ensuring direct, reliable patient access to medical cannabis throughout the state. It also joins the Company's 52 other Florida dispensaries, including those in nearby New Port Richey, Clearwater, and Tampa. Trulieve Cannabis Corp (OTCMKTS:TCNNF) promulgates itself as a company that, through its subsidiary, Trulieve, Inc., engages in the cultivation, possession, distribution, and sale of medical cannabis in the United States. It offers a suite of Trulieve branded products with approximately 125 SKUs, including nasal sprays, capsules, concentrates, syringes, and cannabis flower in tamper-proof containers for vaporizers, topical creams, tinctures, and vape cartridges.  According to company materials, “Trulieve is a vertically integrated "seed to sale" company and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL.” Trulieve Cannabis Corp (OTCMKTS:TCNNF) distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as takes orders online and by phone for delivery. As of November 20, 2018, the company operated 21 dispensaries. Trulieve Cannabis Corp. is headquartered in Quincy, Florida. Sugarmade Inc (OTCMKTS:SGMD) is in the process of expanding into the LA area for its BudCars cannabis delivery business. This is likely to be a strong source of new strategic growth for a company that has already been posting sequential monthly growth above 30% on the topline for several consecutive months after making its flagship investment in BudCars. At this point, based on recent disclosures from the company, we have a clear sense that, not only is the first LA location on track and simply awaiting some factors no doubt slowed by the pandemic – city council isn’t exactly on vacation right now. Crisis mode is the standard setting for most administrative affairs in local government around the country right now. However, the other key piece here is that the second LA BudCars location is ahead of schedule. That’s perhaps even more important here. Sugarmade Inc (OTCMKTS:SGMD) also recently issued a mid-month performance update for the month of July, which was on pace to set multiple new Company performance records at the time for sales, gross profits, and total customer orders.  According to the release, as of July 14, the Company is now on pace to meet or exceed its target of $650,000 in total sales in July, with well over 5,000 individual customer orders likely this month, suggesting that sequential month-over-month topline growth will be at or above the Company’s target 30% level. “Our BudCars Sacramento hub continues to demonstrate accelerating growth that suggests we still haven’t really found the ceiling here in terms of period-over-period upside potential,” commented Jimmy Chan, CEO of Sugarmade. “Ultimately, this is gratifying to see because we have taken a unique approach to retail cannabis product distribution.” Sugarmade Inc (OTCMKTS:SGMD) has been posting major growth updates on a regular basis over the past couple months as its BudCars model takes apparent flight. The rate of sales growth expected from the company in 2020 has walked up a steep ladder, with the latest guidance suggesting we could see it north of $30 million in annualized sales by year-end. Cresco Labs Inc (OTCMKTS:CRLBF) just announced additional actions in board refreshment and corporate governance to further strengthen its leadership in the cannabis industry, including its move to appoint Carol Vallone. According to the release, Cresco has appointed Carol Vallone to its board of directors, effective immediately. Ms. Vallone is a well-known business leader, former CEO, and corporate board director, with a strong track record in launching, scaling, and managing global companies… In the past, Ms. Vallone served as President and Chief Executive Officer of leading E-learning companies including WebCT Inc., where she grew the online learning company to cover almost two thousand institutions in seventy countries. She has also served on multiple boards at leading non-profit healthcare, public financial services, and e-commerce organizations. CRESCO LABS ORD (OTCMKTS:CRLBF) trumpets itself as a company that manufactures and sells medical cannabis products in the United States. It offers cannabis dry flower; vaporizer forms of cannabis; cannabis oil in capsule, oral and sublingual solutions; cannabis in topical; and other cannabis products.  The company also provides cannabis infused edibles, including chocolate and toffee confections, fruit-forward gummies, and hard sweet and chews. Cresco Labs Inc. sells its products under the Cresco brand.  Cresco Labs Inc (OTCMKTS:CRLBF) operates a Hope Heal Health dispensary in Fall River, Bristol County, Massachusetts.  Read the full article